AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Acambis plus Baxter to make more smallpox vaccine for U.S.

The Philadelphia Inquirer (Philadelphia, PA)

| November 28, 2001 | COPYRIGHT 2007 The Philadelphia Inquirer. (Hide copyright information)Copyright

Byline: Linda Loyd

The government awarded a contract Wednesday to buy 155 million doses of smallpox vaccine to a British/U.S. pharmaceutical venture because its bid came in lowest and it could deliver the vaccine within 12 months.

Secretary of Health and Human Services Tommy Thompson announced that Acambis Inc., teaming with Baxter International Inc., had signed a $428 million contract to bring the nation's stockpile of vaccine to 286 million doses, enough to inoculate every American, by the end of next year.

The cost per dose of vaccine will be $2.76, in line with what the Bush administration proposed to spend.

Health officials said Wednesday they have no plans to resume routine vaccinations that ceased in 1972 when smallpox was considered …

Related articles from newspapers, magazines, journals, and more
Acambis concludes ACAM2000 smallpox vaccine Phase III trials and moves...
News wire article from: Asia Africa Intelligence Wire September 20, 2004 700+ words
ROUNDUP Acambis ruled out of key US smallpox vaccine contract; shares plunge.
News wire article from: Europe Intelligence Wire November 14, 2006 700+ words
Acambis: Smallpox vaccine and trading update.
News wire article from: Asia Africa Intelligence Wire January 15, 2004 700+ words
Acambis wins US smallpox vaccine contract.
News wire article from: Europe Intelligence Wire September 30, 2004 700+ words
Study describes advantages of Acambis' clonal smallpox vaccine.
News wire article from: Asia Africa Intelligence Wire August 19, 2003 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily